Oncopeptides AB (publ) (STO:ONCO)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.570
-0.013 (-0.82%)
Aug 13, 2026, 5:29 PM CET

Oncopeptides AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-221.1-249.59-284.61-249.11-337.95-1,430
Depreciation & Amortization
9.679.679.7511.0416.8414.57
Other Amortization
----0.320.42
Asset Writedown & Restructuring Costs
-----16.59
Stock-Based Compensation
2.722.7210.9111.514.8114.54
Other Operating Activities
23.9820.136.064.14-3.84-94.11
Change in Accounts Receivable
8.548.54-4.3-16.0253.1724.66
Change in Inventory
-3.87-3.87-1.95-2.42-1.46-0.32
Change in Accounts Payable
-17.47-17.473.15-13.19-22.89-104.91
Change in Other Net Operating Assets
-2.626.990.42-25.42-139.5242.49
Operating Cash Flow
-200.16-222.88-260.57-279.49-420.51-1,516
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
---0.36-0.12-2.51-0.34
Investment in Securities
--0.85-0--
Other Investing Activities
--00--
Investing Cash Flow
--0.5-0.12-2.51-0.34

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--8.16-8.03-9.14-15.54-15.41
Net Debt Issued (Repaid)
-8.16-8.16-8.03-9.14-15.54-15.41
Issuance of Common Stock
151.41151.41313.48116.02436.021,116
Other Financing Activities
157.51-14.7-41.64--28.07-67.05
Financing Cash Flow
300.76128.55263.81106.89392.41,034

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-2.67-1.951.391.6112.944.63
Miscellaneous Cash Flow Adjustments
----0--0
Net Cash Flow
97.93-96.285.13-171.11-17.67-478.07

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-200.16-222.88-260.93-279.61-423.02-1,517
Free Cash Flow Growth
------
Free Cash Flow Margin
-240.47%-313.40%-824.47%-793.89%-5063.03%-1282.16%
Free Cash Flow Per Share
-0.83-0.98-1.57-3.09-5.14-20.14
Levered Free Cash Flow
-120.11-138.49-169.03-191.36-289.31-1,086
Unlevered Free Cash Flow
-111.57-129.46-161.12-187.74-288.76-1,086

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
4.932.800.570.880.95
Cash Income Tax Paid
0.090.11-0.59-1.650.0412.22
Change in Working Capital
-15.42-5.82-2.68-57.06-110.69-38.08